Clinical trial
OpT2mise Glucose Control in Type 2 DM With Insulin Pump Therapy
NCT01182493 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OpT2mise Glucose Control in Type 2 DM With Insulin Pump Therapy
- Lead sponsor
- Medtronic MiniMed, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- August 31, 2014
- Enrollment
- 331 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.